Abstract:Objective: Although second trimester maternal plasma corticotropin-releasing hormone concentrations are elevated in women who are destined to deliver preterm, the sensitivity and positive predictive value of an individual test of corticotropin-releasing hormone concentration is low. This poor screening performance may be due in part to the observation that the causes of preterm delivery are heterogenous, with potentially different effects on corticotropin-releasing hormone production. We have reanalyzed data from a previous cohort of women with multiple samplings to determine whether the trajectory of increase of placental corticotropin-releasing hormone provided more information than did a single sample. Study design: In this cohort, where 2 to 4 samples that had been assayed for corticotropin-releasing hormone were available on 305 women, the general form of the exponential equation y = ae(bt) was fitted to the corticotropin-releasing hormone data of each individual by the Gauss-Newton nonlinear least squares method, which generated the parameters, y-intercept and rate of rise, in corticotropin-releasing hormone concentration for each woman. Nonparametric statistical techniques, including bootstrapping, were applied to compare the results for the group of women who delivered at term with the group of women who delivered spontaneously preterm and the group of women who were delivered preterm by induction or cesarean delivery because of obstetric indication. Results: The 3 clinically defined groups have significantly different parameters, y-intercept and rate of rise, which describe the corticotropin-releasing hormone trajectory. The group that delivered preterm because of obstetric indications had a similar mean y-intercept but significantly greater mean rate of rise in corticotropin-releasing hormone concentration than the term group (0.3491 vs 0.1788; 95% CI, 0.2331-0.4615 vs 0.1394-0.2330). The group that delivered spontaneously preterm had a significantly greater mean y-intercept than the group that delivered preterm because of obstetric indication (17.08 vs 1.83; 95% CI, 5.89-28.43 vs 0.03-5.19) but a similar mean rate of rise to the group that delivered at term. Conclusion: These data suggest that spontaneous preterm delivery is associated with an abnormal setting of the production of corticotropin-releasing hormone that is present from very early in pregnancy, although women who experience an induced preterm delivery are characterized by rapidly rising placental corticotropin-releasing hormone concentrations. These data further suggest that clinical abnormalities that are associated with preterm delivery by induction or cesarean delivery are associated with abnormalities that lead to a rapidly increasing corticotropin-releasing hormone concentrations. Trajectories for corticotropin-releasing hormone provide information beyond that obtained from a single sample.

Study on the relationship between Corticotropin-Releasing Hormone Receptor 1 and onset of labor

The Clinical Study of the Role of Corticotropin-Releasing Hormone in Preterm Labor

Corticotropin-releasing Hormone Activates Connexin 43 Via Activator Protein-1 Transcription Factor in Human Myometrial Smooth Muscle Cells.

Human Labour Is Associated With A Decline In Myometrial Chemokine Receptor Expression: The Role Of Prostaglandins, Oxytocin And Cytokines

[A Pilot Study on Relationship of Periodontal Status, Serum Level of Interleukin-1Beta and Delivery Outcomes in Pregnant Women].

Elevated expression of Toll-like receptor 4 and cytokines in both serum and myometrium at term may serve as promising biomarkers for uterine activation preceding labor

Changes of serum cortisol during pregnancy and labor initiation: an onsite cross-sectional study

Study of the factors affecting serum C-reactive protein after delivery

Value of levels of serumβ-chorionic gonadotropin and C-reactive protein in prediction of intrauterine infection of premature rupture of membranes and evaluation of prognosis

The Role of Formyl Peptide Receptor 1 in Uterine Contraction During Parturition

Expression of Relaxant EP2 and Contractile FP in Human Lower Segment Myometrium in Term Pregnancy and Labor

[Expression of Calponin-1 and Transgelin in Human Uterine Smooth Muscles in Non-Labor and Labor Situation].

Interaction between NF-κB and AP-1 and their intracellular localization at labor in human late pregnant myometrial cells in vivo and in vitro

Maternal plasma corticotropin-releasing hormone trajectories vary depending on the cause of preterm delivery

Chemokine and cytokine profiles in preterm and term labor, in preterm prelabor rupture of the membranes, and in normal pregnancy

Laboratory markers to identify acute histological chorioamnionitis in febrile parturients undergoing epidural analgesia: a retrospective study

Corticotropin releasing hormone modulates endotoxin-induced inflammatory cytokine expression in human trophoblast cells

[Scanning of drug targets related to uterus contraction from the uterine smooth muscles by cDNA microarray]

[Study of the correlation between gonadotropin- and prolactin-releasing systems in women in the luteal phase and early pregnancy]

Elevated inflammatory mediators from the maternal-fetal interface to fetal circulation during labor

Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.